Accel Research Sites specializes in conducting Phase I/IIa clinical pharmacology studies, providing a comprehensive service for sponsors seeking to evaluate the safety and tolerability of new drug candidates in early-stage clinical trials. Our experienced team and flexible research sites ensure efficient and reliable data collection.